16-88643538-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_000101.4(CYBA):c.403G>A(p.Glu135Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000575 in 1,535,006 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E135Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_000101.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYBA | NM_000101.4 | c.403G>A | p.Glu135Lys | missense_variant | 6/6 | ENST00000261623.8 | |
CYBA | XM_011522905.4 | c.*1628G>A | 3_prime_UTR_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYBA | ENST00000261623.8 | c.403G>A | p.Glu135Lys | missense_variant | 6/6 | 1 | NM_000101.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00281 AC: 428AN: 152086Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000706 AC: 93AN: 131780Hom.: 0 AF XY: 0.000677 AC XY: 49AN XY: 72330
GnomAD4 exome AF: 0.000328 AC: 454AN: 1382812Hom.: 1 Cov.: 37 AF XY: 0.000296 AC XY: 202AN XY: 682780
GnomAD4 genome AF: 0.00281 AC: 428AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.00250 AC XY: 186AN XY: 74406
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 28, 2016 | The E135K variant has been published previously as as a benign variant (Rae et al., 2000). The NHLBI Exome Sequencing Project reports the variant was observed in 9/2910 (0.31%) alleles from individuals of African-American background, and the 1000 Genomes Project Consortium reports E135K was observed in 18/1322 (1.36%) alleles from individuals of African background, indicating it may be a rare variant in these populations. However, the variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 19, 2016 | - - |
CYBA-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 25, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 27, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at